STUDY OF POSTNATAL EFFECT OF CHEMOPREVENTIVE AGENTS ON ETHYLNITROSOUREA-INDUCED TRANSPLACENTAL CARCINOGENESIS IN RATS .3. INHIBITORY-ACTIONOF INDOMETHACIN, VOLTAREN, THEOPHYLLINE AND EPSILON-AMINOCAPROIC ACID
Va. Alexandrov et al., STUDY OF POSTNATAL EFFECT OF CHEMOPREVENTIVE AGENTS ON ETHYLNITROSOUREA-INDUCED TRANSPLACENTAL CARCINOGENESIS IN RATS .3. INHIBITORY-ACTIONOF INDOMETHACIN, VOLTAREN, THEOPHYLLINE AND EPSILON-AMINOCAPROIC ACID, Carcinogenesis, 17(9), 1996, pp. 1935-1939
The influence of the arachidonic acid metabolism inhibitors, indometha
cin and voltaren; an inhibitor of phosphodiesterase activity, theophyl
line and the protease inhibitor epsilon-aminocaproic acid (EACA) on N-
ethyl-N-nitrosourea (ENU)-induced transplacental carcinogenesis was st
udied in rats. ENU was given to pregnant rats as a single i.v. exposur
e at a dose of 75 mg/kg body weight on the 21st day after conception,
Indomethacin and voltaren (20 p.p.m. in drinking water), theophylline
(0.01% in diet) and EACA (1000 p.p.m. in drinking water) were given to
the offspring throughout their post-natal life until all survivors we
re killed at 12 months, In the ENU-only control groups, 100% of the of
fspring developed tumors of brain, spinal cord, peripheral nervous sys
tem or kidneys, with a total average number of 3.1 tumors per rat, The
most marked inhibitory effect was exerted by theophylline, which sign
ificantly decreased the incidence and multiplicity of total tumors, an
d at all main sites selectively (brain, spinal cord, peripheral nerves
and kidneys), It also prolonged average survival time of the offsprin
g, Indomethacin and voltaren significantly decreased total tumor incid
ence and multiplicity, and brain tumor incidence and multiplicity, Ind
omethacin also decreased kidney tumor multiplicity and voltaren dimini
shed spinal cord tumor multiplicity, EACA decreased multiplicities of
total, brain, peripheral nerve and kidney tumors, and diminished the i
ncidence of brain tumors, These chemopreventive agents decreased tumor
incidences 20-33% and tumor multiplicities 1.4-2.7 times, compared wi
th the ENU-only controls.